Atea Pharmaceuticals Inc (AVIR): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 9,417 US Dollar | 1 | 0 | 1 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 80.204.699 | 12,33 | 21,62 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Atea Pharmaceuticals Inc
Mitarbeiter 55
Handelsplatz NASDAQ
Ticker Symbol AVIR
IPO Datum 2020-10-30
Adresse 225 Franklin Street, Boston, MA, United States, 02110
Webseite https://ateapharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jean-Pierre Sommadossi Ph.D. | Founder, Chairman, CEO & President |
| 2 | Ms. Andrea J. Corcoran J.D. | CFO, Executive VP of Legal & Secretary |
| 3 | Mr. John F. Vavricka | Chief Commercial Officer |
| 4 | Dr. Janet M. J. Hammond M.D., Ph.D. | Chief Development Officer |
| 5 | Dr. Maria Arantxa Horga M.D. | Chief Medical Officer |
| 6 | Mr. Wayne Foster CPA | Executive VP of Finance & Chief Accounting Officer |
| 7 | Ms. Jonae R. Barnes | Senior Vice President of Investor Relations & Corporate Communications |
| 8 | Mr. Adel Moussa Ph.D. | Executive Vice President of Chemistry |
| 9 | Mr. Xiao-Jian Zhou Ph.D. | Executive Vice President of Early Stage Development |
| 10 | Mr. Keith Pietropaolo | Executive VP of Clinical Sciences & Project Management |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,90% | 68,12 Mio. USD |
| 2 | BlackRock Inc | 10,52% | 48,08 Mio. USD |
| 3 | BML Capital Management LLC | 8,67% | 39,63 Mio. USD |
| 4 | TANG CAPITAL MANAGEMENT LLC | 6,00% | 27,44 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 4,05% | 18,50 Mio. USD |
| 6 | Bain Capital Life Sciences Investors, LLC | 2,94% | 13,46 Mio. USD |
| 7 | Two Sigma Investments LLC | 2,32% | 10,63 Mio. USD |
| 8 | Geode Capital Management, LLC | 2,18% | 9,96 Mio. USD |
| 9 | State Street Corp | 2,11% | 9,66 Mio. USD |
| 10 | Acadian Asset Management LLC | 1,97% | 9,02 Mio. USD |
| 11 | Dimensional Fund Advisors, Inc. | 1,62% | 7,41 Mio. USD |
| 12 | Rosalind Advisors, Inc. | 1,46% | 6,68 Mio. USD |
| 13 | Renaissance Technologies Corp | 1,45% | 6,65 Mio. USD |
| 14 | JPMorgan Chase & Co | 1,17% | 5,36 Mio. USD |
| 15 | Morgan Stanley - Brokerage Accounts | 0,91% | 4,17 Mio. USD |
| 16 | Curated Wealth Partners LLC | 0,87% | 3,96 Mio. USD |
| 17 | Charles Schwab Investment Management Inc | 0,74% | 3,40 Mio. USD |
| 18 | The Goldman Sachs Group Inc | 0,73% | 3,35 Mio. USD |
| 19 | Northern Trust Corp | 0,73% | 3,34 Mio. USD |
| 20 | Vanguard Portfolio Management, LLC | 0,70% | 3,18 Mio. USD |